Curated By Nelson Vergel | ExcelMale.com | Updated March 2026
Key Takeaways
Retatrutide is a first-in-class triple hormone receptor agonist (GLP-1 + GIP + glucagon) from Eli Lilly, currently in Phase 3 clinical trials under the TRIUMPH program.
In Phase 3 (TRIUMPH-4), participants on the...